Abstract
An assessment of therapeutic approaches for the treatment of bronchitis, emphysema, cystic fibrosis, pulmonary fibrosis and ARDS. This review is based on analysis of the patents published in the period January 1993 to August 1997. A consideration of distinct therapeutic approaches to each of these diseases and an assessment of where approaches may be used to treat more than one such disease. An indication of major corporate involvement in each area is also provided.